These Houston-area entrepreneurs have something to celebrate this week. Photos courtesy of EY

Four entrepreneurs whose companies are in or near the Houston metro area have been named winners in Ernst & Young’s Entrepreneur Of The Year regional competition and now will head to the national competition.

Local winners of the Entrepreneur Of The Year 2022 Central South Award are:

  • Elliott Bouillion, founder and executive chairman of Bellaire-based Resource Environmental Solutions. The company helps clients with environmental mitigation, stormwater management and water quality, and climate adaptation and flood resilience.
  • Blake Brannon, founder and president of Brenham-based Brannon Industrial Group. The company buys and recycles scrap metal, provides waste and recycling services, rents out portable toilets, and offers sustainable printing services.
  • Dr. Juliet Breeze, founder and CEO of Houston-based Next Level Medical, which operates membership-model urgent care clinics.
  • Jamie Welch, president, CEO, and chief financial officer of Houston-based Kinetic Holdings, a midstream oil and natural gas operator in the Delaware Basin of West Texas and northern New Mexico.

Among the criteria used to select the regional winners were purpose, growth, impact, and entrepreneurial spirit.

“Each of these entrepreneurs has exhibited curiosity, ingenuity, and courage, and we are proud to celebrate this outstanding group of leaders and welcome them as valuable members of our Entrepreneur Of The Year community,” says Anna Tallent, co-director of the awards’ Central South program.

As regional award winners, these entrepreneurs will be considered for the Entrepreneur Of The Year 2022 national awards, which will be presented in November. The overall Entrepreneur Of The Year winner at the national level then will move on to the EY World Entrepreneur Of The Year program, which will name its top winner in June 2023.

In a news release, Breeze says she’s honored to be given such a prestigious award.

“This award is further validation that at Next Level, we are really on to something. Healthcare needs to be available to patients when and where they need it,” Breeze says.

Aside from the Houston-area winners, here are the other recipients of this year’s Entrepreneur Of The Year Central South Award:

  • CEO Amanda Baldwin and founder and Chairwoman Holly Thaggard of San Antonio-based Supergoop! The company makes and sells sunscreen-based skincare products.
  • Cory Brymer, founder and CEO of Hutto-based BryComm, a provider of technology and security infrastructure services.
  • William Chan, co-founder and CEO of Austin-based Iodine Software, a provider of AI-powered software for the healthcare industry.
  • Todd Dipaola, founder and CEO of Austin-based InMarket, which operates a platform for localized advertising.
  • Dr. David Ferguson, co-founder, president, and CEO of San Antonio-based Celebrate Dental & Braces, which has offices in five states.
  • Mark Floreani, co-founder and CEO of Austin-based FloSports, a streaming service for sporting events.
  • James Garvey, founder and CEO of Austin-based Self Financial, which offers credit-building loans.
  • Tim Heyl, founder and CEO of Austin-based Homeward, whose loans help buyers make all-cash offers for homes.
  • Joel Kocher, co-founder and CEO of Austin- based HumanN, a provider of superfood products.
  • JeVon McCormick, president and CEO of Austin-based book publisher Scribe Media.
  • Thomas Thill, CEO of San Antonio-based AmeriVet Veterinary Partners, an owner and operator of veterinary practices.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston doctors recognized among top creative leaders in business

winners

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Samsung sets sights on nearly $200 billion expansion in Texas

chipping in

As it builds a $17 billion chipmaking factory in Taylor, tech giant Samsung is eyeing a long-term strategy in the Texas area that could lead to a potential investment of close to $200 billion.

Samsung’s plans, first reported by the Austin Business Journal, call for an additional $192.1 billion investment in the Austin area over several decades that would create at least 10,000 new jobs at 11 new chipmaking plants. These facilities would be at the new Taylor site and the company’s existing site in Northeast Austin.

The first of the 11 new plants wouldn’t be completed until 2034, according to the Business Journal.

“Samsung has a history already in the Austin market as an employer of choice, providing high wages, great benefits, and a great working environment. All of this will be on steroids in the not-too-distant future, creating a historic boost to the already booming Austin economy,” John Boyd Jr., a corporate site selection consultant, tells CultureMap.

Samsung’s preliminary plans were revealed in filings with the State of Texas seeking possible financial incentives for the more than $190 billion expansion. The South Korean conglomerate says the filings are part of the company’s long-range planning for U.S. chipmaking facilities.

Given that Samsung’s 11 new plants would be decades in the making, there’s no certainty at this point that any part of the potential $192.1 billion expansion will ever be built.

Last November, Samsung announced it would build a $17 billion chipmaking factory in Taylor to complete its semiconductor operations in Northeast Austin. Construction is underway, with completion set for 2024. Boyd proclaimed last year that the Taylor project will trigger an “economic tsunami” in the quiet Williamson County suburb.

The Taylor facility, which is expected to employ more than 2,000 people, ranks among the largest foreign economic development projects in U.S. history. The impact of a nearly $200 billion cluster of 11 new chipmaking plants would far eclipse the Taylor project.

The Taylor factory will produce advanced chips that power mobile and 5G capabilities, high-performance computing, and artificial intelligence.

------

This article originally ran on CultureMap.